These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 36411574)

  • 1. FASN Inhibitors Enhance Bestatin-Related Tumor Cell Apoptosis Through Upregulating PEPT1.
    Ni J; Shang Y; Wang WD; Wang C; Wang AM; Li GJ; Chen SZ
    Curr Mol Pharmacol; 2023; 16(7):771-786. PubMed ID: 36411574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of fatty acid synthase in human gliomas correlates with the WHO tumor grade and inhibition with Orlistat reduces cell viability and triggers apoptosis.
    Grube S; Dünisch P; Freitag D; Klausnitzer M; Sakr Y; Walter J; Kalff R; Ewald C
    J Neurooncol; 2014 Jun; 118(2):277-287. PubMed ID: 24789255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fatty acid synthase inhibitors induce apoptosis in non-tumorigenic melan-a cells associated with inhibition of mitochondrial respiration.
    Rossato FA; Zecchin KG; La Guardia PG; Ortega RM; Alberici LC; Costa RA; Catharino RR; Graner E; Castilho RF; Vercesi AE
    PLoS One; 2014; 9(6):e101060. PubMed ID: 24964211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of fatty acid synthase inhibitors on lymphatic vessels: an in vitro and in vivo study in a melanoma model.
    Bastos DC; Paupert J; Maillard C; Seguin F; Carvalho MA; Agostini M; Coletta RD; Noël A; Graner E
    Lab Invest; 2017 Feb; 97(2):194-206. PubMed ID: 27918556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fatty acid synthase overexpression: target for therapy and reversal of chemoresistance in ovarian cancer.
    Bauerschlag DO; Maass N; Leonhardt P; Verburg FA; Pecks U; Zeppernick F; Morgenroth A; Mottaghy FM; Tolba R; Meinhold-Heerlein I; Bräutigam K
    J Transl Med; 2015 May; 13():146. PubMed ID: 25947066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic and toxicologic evaluation of anti-lipogenic agents in cancer cells compared with non-neoplastic cells.
    Deepa PR; Vandhana S; Jayanthi U; Krishnakumar S
    Basic Clin Pharmacol Toxicol; 2012 Jun; 110(6):494-503. PubMed ID: 22151915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitory effect of emodin on fatty acid synthase, colon cancer proliferation and apoptosis.
    Lee KH; Lee MS; Cha EY; Sul JY; Lee JS; Kim JS; Park JB; Kim JY
    Mol Med Rep; 2017 Apr; 15(4):2163-2173. PubMed ID: 28260110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of fatty acid synthase in melanoma cells activates the intrinsic pathway of apoptosis.
    Zecchin KG; Rossato FA; Raposo HF; Melo DR; Alberici LC; Oliveira HC; Castilho RF; Coletta RD; Vercesi AE; Graner E
    Lab Invest; 2011 Feb; 91(2):232-40. PubMed ID: 20805790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of Fatty Acid Synthase (FASN) synergistically enhances the efficacy of 5-fluorouracil in breast carcinoma cells.
    Vazquez-Martin A; Ropero S; Brunet J; Colomer R; Menendez JA
    Oncol Rep; 2007 Oct; 18(4):973-80. PubMed ID: 17786362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dietary soy protein inhibits DNA damage and cell survival of colon epithelial cells through attenuated expression of fatty acid synthase.
    Xiao R; Su Y; Simmen RC; Simmen FA
    Am J Physiol Gastrointest Liver Physiol; 2008 Apr; 294(4):G868-76. PubMed ID: 18239060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fatty acid synthase inhibitors cerulenin and C75 retard growth and induce caspase-dependent apoptosis in human melanoma A-375 cells.
    Ho TS; Ho YP; Wong WY; Chi-Ming Chiu L; Wong YS; Eng-Choon Ooi V
    Biomed Pharmacother; 2007 Oct; 61(9):578-87. PubMed ID: 17904792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological inhibitors of Fatty Acid Synthase (FASN)--catalyzed endogenous fatty acid biogenesis: a new family of anti-cancer agents?
    Lupu R; Menendez JA
    Curr Pharm Biotechnol; 2006 Dec; 7(6):483-93. PubMed ID: 17168665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fatty acid synthase inhibitor orlistat induces apoptosis in T cell lymphoma: role of cell survival regulatory molecules.
    Kant S; Kumar A; Singh SM
    Biochim Biophys Acta; 2012 Nov; 1820(11):1764-73. PubMed ID: 22877747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fatty acid synthase inhibition results in a magnetic resonance-detectable drop in phosphocholine.
    Ross J; Najjar AM; Sankaranarayanapillai M; Tong WP; Kaluarachchi K; Ronen SM
    Mol Cancer Ther; 2008 Aug; 7(8):2556-65. PubMed ID: 18723500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FASN inhibition sensitizes metastatic OSCC cells to cisplatin and paclitaxel by downregulating cyclin B1.
    Almeida LY; Moreira FDS; Santos GASD; Cuadra Zelaya FJM; Ortiz CA; Agostini M; Mariano FS; Bastos DC; Daher URN; Kowalski LP; Coletta RD; Graner E
    Oral Dis; 2023 Mar; 29(2):649-660. PubMed ID: 34510641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fatty acid synthase inhibitor cerulenin inhibits topoisomerase I catalytic activity and augments SN-38-induced apoptosis.
    Jeong NY; Lee JS; Yoo KS; Oh S; Choe E; Lee HJ; Park BS; Choi YH; Yoo YH
    Apoptosis; 2013 Feb; 18(2):226-37. PubMed ID: 23108760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased fatty acid synthase as a potential therapeutic target in multiple myeloma.
    Wang WQ; Zhao XY; Wang HY; Liang Y
    J Zhejiang Univ Sci B; 2008 Jun; 9(6):441-7. PubMed ID: 18543396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of fatty-acid synthase suppresses P-AKT and induces apoptosis in bladder cancer.
    Jiang B; Li EH; Lu YY; Jiang Q; Cui D; Jing YF; Xia SJ
    Urology; 2012 Aug; 80(2):484.e9-15. PubMed ID: 22554590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor growth retardation and chemosensitizing action of fatty acid synthase inhibitor orlistat on T cell lymphoma: implication of reconstituted tumor microenvironment and multidrug resistance phenotype.
    Kant S; Kumar A; Singh SM
    Biochim Biophys Acta; 2014 Jan; 1840(1):294-302. PubMed ID: 24060750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD13 inhibition augments DR4-induced tumor cell death in a p-ERK1/2-independent manner.
    Ni J; Wang X; Shang Y; Li Y; Chen S
    Cancer Biol Med; 2021 Mar; 18(2):569-86. PubMed ID: 33710811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.